person
as of 2026-07-01Lurasidone Medical Director, MD
Lurasidone Medical Director
at a glance
Roles: Study Director
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Sumitomo Pharma America, Inc.
Roles
Study Director
Trial investigator
no
Trials led
6
Lurasidone Low-Dose - High-Dose Study Study
NCT01821378Phase 3Completed
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
NCT01143077Phase 3Completed
Lurasidone Pediatric Pharmacokinetics Study
NCT01620060Phase 1Completed
Pediatric Schizophrenia Efficacy and Safety Study
NCT01911429Phase 3Completed
Pediatric Open-Label Extension Study
NCT01914393Phase 3Completed
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
NCT01566162Phase 3Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR